Company attributes
Industry
Location
Legal Name
Shenzhen Efung Investment Management Co. Ltd.
Number of Employees (Ranges)
11 – 500
Full Address
3rd Fuzhong Rd, 1006, Shenzhen, Guangdong -, CN0
Founded Date
1996
0Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Short Name
EFung Capital
Shenzhen Efung Investment Management (Efung Capital) is a Shenzhen based life science venture capital firm. They focus investments in clinical-stage pharmaceutical and medical device companies already generating revenues. They look for investment in China and the United States.
Investment
Efung Capital has made investments in WeMed, Elicio Therapeutics, TriArm Therapeutics, Zhongyianke Biotech, Tactiva Therapeutics, KBP Biosciences, Centrexion Therapeutics, Ascentage Pharma, Chipscreen Biosciences, Frontier Biotech, Lifotronic, Healthgen Biotech, Aridis Pharmaceuticals, and Resverlogix.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
